Agilent Technologies Return on Tangible Equity 2010-2025 | A
Current and historical return on tangible equity values for Agilent Technologies (A) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Agilent Technologies Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-04-30 | $1.17B | $1.17B | 99.85% |
| 2025-01-31 | $1.26B | $1.08B | 94.34% |
| 2024-10-31 | $1.29B | $0.87B | 85.48% |
| 2024-07-31 | $1.41B | $1.55B | 86.05% |
| 2024-04-30 | $1.24B | $1.83B | 81.52% |
| 2024-01-31 | $1.24B | $1.78B | 93.94% |
| 2023-10-31 | $1.24B | $1.41B | 115.32% |
| 2023-07-31 | $1.13B | $1.07B | 132.40% |
| 2023-04-30 | $1.35B | $1.00B | 204.31% |
| 2023-01-31 | $1.32B | $0.82B | 277.07% |
| 2022-10-31 | $1.25B | $0.53B | 370.18% |
| 2022-07-31 | $1.33B | $0.29B | 422.93% |
| 2022-04-30 | $1.26B | $0.27B | 561.33% |
| 2022-01-31 | $1.21B | $0.26B | 1258.49% |
| 2021-10-31 | $1.21B | $0.43B | 928.98% |
| 2021-07-31 | $0.99B | $-0.06B | 750.00% |
| 2021-04-30 | $0.93B | $-0.25B | 339.76% |
| 2021-01-31 | $0.81B | $0.40B | 202.12% |
| 2020-10-31 | $0.72B | $0.44B | 204.84% |
| 2020-07-31 | $0.69B | $0.50B | 273.12% |
| 2020-04-30 | $0.68B | $0.27B | 166.38% |
| 2020-01-31 | $0.76B | $0.20B | 107.15% |
| 2019-10-31 | $1.07B | $0.05B | 107.40% |
| 2019-07-31 | $1.07B | $1.13B | 84.94% |
| 2019-04-30 | $1.12B | $1.48B | 88.67% |
| 2019-01-31 | $1.14B | $1.34B | 86.87% |
| 2018-10-31 | $0.32B | $1.11B | 23.13% |
| 2018-07-31 | $0.30B | $1.12B | 19.15% |
| 2018-04-30 | $0.24B | $1.69B | 14.09% |
| 2018-01-31 | $0.20B | $1.55B | 12.10% |
| 2017-10-31 | $0.68B | $1.87B | 43.77% |
| 2017-07-31 | $0.63B | $1.62B | 44.44% |
| 2017-04-30 | $0.58B | $1.43B | 42.70% |
| 2017-01-31 | $0.51B | $1.33B | 39.63% |
| 2016-10-31 | $0.46B | $1.31B | 37.96% |
| 2016-07-31 | $0.48B | $1.38B | 38.75% |
| 2016-04-30 | $0.46B | $1.12B | 38.66% |
| 2016-01-31 | $0.46B | $1.06B | 36.90% |
| 2015-10-31 | $0.40B | $1.36B | 30.56% |
| 2015-07-31 | $0.28B | $1.26B | 18.35% |
| 2015-04-30 | $0.31B | $1.30B | 18.82% |
| 2015-01-31 | $0.37B | $1.33B | 20.61% |
| 2014-10-31 | $0.50B | $2.15B | 27.14% |
| 2014-07-31 | $0.69B | $1.87B | 42.56% |
| 2014-04-30 | $0.71B | $1.74B | 52.01% |
| 2014-01-31 | $0.74B | $1.57B | 58.57% |
| 2013-10-31 | $0.72B | $1.33B | 61.70% |
| 2013-07-31 | $0.94B | $0.85B | 84.47% |
| 2013-04-30 | $1.01B | $1.31B | 91.47% |
| 2013-01-31 | $1.10B | $1.21B | 75.26% |
| 2012-10-31 | $1.15B | $1.07B | 64.66% |
| 2012-07-31 | $1.02B | $0.84B | 48.55% |
| 2012-04-30 | $1.10B | $2.73B | 45.53% |
| 2012-01-31 | $1.05B | $2.49B | 47.26% |
| 2011-10-31 | $1.01B | $2.32B | 51.80% |
| 2011-07-31 | $1.02B | $2.16B | 59.87% |
| 2011-04-30 | $0.89B | $1.91B | 64.48% |
| 2011-01-31 | $0.80B | $1.42B | 58.35% |
| 2010-10-31 | $0.68B | $1.29B | 46.86% |
| 2010-07-31 | $0.42B | $0.90B | 26.71% |
| 2010-04-30 | $0.19B | $1.86B | 11.00% |
| 2010-01-31 | $-0.02B | $1.79B | -0.95% |
| 2009-10-31 | $-0.03B | $1.69B | -1.87% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $34.480B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |